Quercetin is a natural bioactive flavonoid that is present in a wide variety of vegetables and fruits and exhibits a promising anti-metastasis property in various human cancer cells. However, the effect of quercetin on human HCCLM3 cells is unclear.
Background
Hepatocellular carcinoma (HCC) is the fifth most common type of cancer in the world and the second leading cause of cancer-related death [1] . Due to liver dysfunction, the lack of effective treatment options, and high rates of metastasis and recurrence, the survival rate of HCC patients remains low [2] . Therefore, potential molecular mechanisms involved in the progress of metastasis in HCC need to be identified.
MMP-2/MMP-9 are members of the matrix metalloproteinase (MMP) family, and both proteins are implicated in tumor migration, invasion, and metastasis in various cancers, like cervical cancer [3] , prostate cancer [4] , and gastric cancer [5, 6] . Moreover, metastasis is inhibited when MMP-2/MMP-9 are down-regulated in the SK HEP 1 and MHcc97H HCC cell lines [7] . Conversely, induction of MMP-2/MMP-9 facilitates metastasis of HCC cells [8] . The PI3K/Akt signaling transduction pathway was reported to participate in the tumor metastasis of HCC [9] [10] [11] . In addition, the PI3K/Akt signaling transduction pathway also plays a critical role in MMP2/MMP-9-mediated tumor cell migration and invasion in various cancers [12] [13] [14] [15] .
Quercetin is a natural flavonoid from the flavonol subclass that is present in a wide variety of vegetables (e.g., onions), fruits (e.g., apples), and red wine [16] . It functions as a pleiotropic molecule with anti-proliferation, anti-oxidant, anti-inflammatory, and anti-cancer properties [17] . In addition, quercetin was recently shown to have inhibitory effects on cell migration and cell invasion in breast cancer cells [18, 19] , oral cancer cells [20] , glioblastoma cells [21] , prostate cancer cells [22] , and melanoma cells [23] . Recent evidence demonstrated that quercetin can inhibit cancer cell migration and invasion by reducing the protein level of MMP-2/MMP-9 [20] . Moreover, quercetin also has been reported to regulate the ability to migrate and invade in various cancers by inhibiting Akt phosphorylation through the PI3K/Akt signaling transduction pathway [24, 25] .
Despite the evidence showing the anti-metastatic potential of quercetin in various tumors, the effect of quercetin on human HCCLM3 cells remains unclear. Therefore, the current study investigated the effects of quercetin on the migration and invasion of human HCCLM3 cells and explored its potential underlying mechanisms.
Material and Methods

Reagents and antibodies
Quercetin was procured from Sigma (St. Louis, MO). Akt1 antibodies (1: 1000 dilution), p-Akt1 (1: 1000 dilution), MMP-2 (1: 500 dilution), and MMP-9 (1: 1000 dilution) were all obtained from Cell Signaling Technology, Beverly, MA. We obtained b-actin (1: 1000 dilution) from Santa Cruz (CA).
Cell culture and treatment
The HCCLM3 cells (human hepatocarcinoma cell line) were received from the China Center for Type Culture Collection (CCTCC, Wuhan, China). The HCCLM3 cells were cultured in RPMI-1640 medium (Invitrogen) with 10% fetal bovine serum (FBS). Cells were incubated at 37°C in an incubator with 5% CO 2 . Cells were passaged when they reached 70-80% confluence.
Wound-healing assay HCCLM3 cells were cultured in 6-well plates at 5×10 5 , and the cells were scratched using a 200-μL pipette tip when they grew to 90% confluence. Then, the cells were washed twice using PBS, and the RPMI-1640 medium was completely changed. Then, we added the different concentrations of quercetin into the wounded cells and incubated them for 36 h. Photos of the wound were taken at 0 and 36 h, and 7 randomly fields were used to assess cell migration ability by using microscopy.
Transwell migration assay
The anti-migration effect of quercetin in HCCLM3 cells was detected by using Transwell assays. In the upper chamber, 4×10 4 cells were cultured in 600 μL of RPMI-1640 medium with different concentrations of quercetin. In the lower chamber, 800 μL of RPMI-1640 medium with 10% FBS was added. After incubation for 36 h at 37°C, the upper chamber was cleaned by using a cotton swab to clean out the cells that were not migrated. The migrated cells were routinely processed by fixing in 4% formalin for 10 min, then stained in 0.1% crystal violet for 15 min, and 5 randomly selected fields were captured using microscopy at 100× magnification.
Matrigel invasion assay
The upper chamber was coated with an 80-μL mixture of Matrigel/RPMI1640 medium (1: 5), and 4×10 4 cells were cultured in 600 μL of RPMI-1640 medium with different concentrations of quercetin. In the lower chamber, 800 μL of RPMI-1640 medium with 10% FBS was added. After incubation for 36 h at 37°C, the upper chamber was cleaned by using a cotton swab to clean out the cells that were not migrated. The migrated cells were routinely processed by fixing in 4% formalin for 10 min, then staining in 0.1% crystal violet for 15 min, and 5 randomly selected fields were captured by using microscopy at 100× magnification.
Western blotting
The HCCLM3 cells were treated with different concentrations of quercetin (0 μmol and 40 μmol). Then, the cell lysate was collected and the protein lysates were quantified. The quantified protein lysates were electrophoresed in 10% SDS-PAGE (SDS-polyacrylamide gel) and then was transferred to the PVDF (polyvinylidene difluoride) membranes. After transferring, the PVDF membranes were incubated with the primary antibodies at 4°C overnight. Then, after washing twice with TBST buffer, the PVDF membranes were incubated with secondary antibody for 1 h. Finally, the proteins were visualization with enhanced chemiluminescence method by using the Western blot image-forming system (Tanon 5200, China). All of the experiments were repeated 3 times.
Statistical analysis
Statistical differences from the respective controls for each experimental test condition were compared by ANOVA (oneway analysis of variance) or the t test. The p<0.01 or p<0.05 represented a significant difference. Values are expressed as the mean ±SD.
Results
Quercetin delayed the wound-healing time in human HCCLM3 cells A wound-healing assay was performed using quercetin-treated HCCLM3 cells to further explore whether quercetin affects the motility of human HCCLM3 cells. As shown in Figure 1 , quercetin-treated HCCLM3 cells (20 μmol, 40 μmol, and 60 μmol) migrated more slowly than cells in the control group (0 μmol) at 36 h. Thus, quercetin delayed the wound-healing time in human HCCLM3 cells and inhibited HCCLM3 cell motility in a dose-dependent manner.
Quercetin inhibited the cell migration and invasion in human HCCLM3
Furthermore, a Transwell assay was used to explore the effect of quercetin on the migration and invasion of HCCLM3 cells. As shown in Figure 2A Quercetin down-regulated the protein levels of p-Akt1, MMP-2, and MMP-9 in human HCCLM3
According to previous reports, the PI3K/Akt1 signaling pathway is positively correlated with tumor metastasis [26, 27] , and quercetin was also reported to inhibit p-Akt1 expression in various cancers [12, 28] . Accordingly, Western blotting was used to explore whether the PI3K/Akt1 signaling transduction pathway was necessary for the anti-migration and anti-invasion effects of quercetin on HCCLM3 cells. As shown in Figure 3A and 3B, the administration of 40 μmol quercetin significantly reduced p-Akt1 levels compared with the 0 μmol group (p<0.05). MMP-2/MMP-9 are regulated by the PI3K/Akt1 signaling transduction pathway [29, 30] , and both MMPs have been implicated in the invasion of hepatocellular carcinoma [31, 32] . Therefore, the protein level of MMP-2/MMP-9 was examined in control cells and quercetin-treated cells. After 36-h quercetin treatment, the quercetin-treated cells (40 μmol) expressed a much lower level of the MMP-2/MMP-9 proteins than did control cells (0 μmol). Based on these results, quercetin inhibited the protein levels of p-Akt1, MMP-2, and MMP-9 in the HCCLM3 cell line.
Discussion
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death. Although the therapeutic approaches have improved, the 5-year survival rate of HCC patients after surgical resection remains low due to the high rates of metastasis and recurrence [2] . Quercetin is a natural bioactive flavonoid, widely present in vegetables and fruits [16] , and has exhibited promising anti-metastasis properties in various human cancer cells, both in vitro or/and in vivo, including breast cancer [18, 19] , oral cancer cells [20] , glioblastoma [21] , prostate cancer [22] and melanoma [23] . Evidences from human head and neck squamous cell carcinoma shows that quercetin dose-dependently delayed wound-healing time in both HSC-3 and FaDu cells [33] . However, the effect of quercetin on cell migration and invasion has been less clearly defined. In the present study, quercetin delayed the wound-healing time in HCCLM3 cells (Figure 1, p<0.05 ), indicating the inhibitory effects of quercetin on HCCLM3 cell motility. Moreover, the results from the Transwell assay also suggest that quercetin inhibits cell migration and invasion in HCCLM3 cells (Figure 2, p<0.05) .
A previous study indicated that quercetin had remarkable effects in suppressing cell migration in renal cell carcinoma cells by altering AKT-mTOR-ERK1/2 signaling pathways [28] . However, whether the expression of p-Akt1 was altering by treating with quercetin in HCCLM3 cell has been unclear. Accordingly, we assessed the Figure 3A, p<0.05 ), suggesting that quercetin inhibits p-Akt1 expression in HCCLM3 cells.
Moreover, MMP-2 and MMP-9 have been found to be involved in tumor migration, invasion, and metastasis in various cancers, and a previous study indicated that these inhibitory effects of quercetin on cell migration are due to suppressing the expression of MMP2 or/and MMP9 through altering the PI3K/Akt signaling pathway. Previous studies indicated that quercetin significantly inhibited cell migration and invasion in breast cancer cells [19] and glioma cells [24] by down-regulating the expression of p-Akt and MMP9. In the present study, as shown in Figure 3B and 3C, the expression of MMP2 and MMP9 was significantly decreased in quercetin-treated HCCLM3 cells (p<0.05). These results suggest that these inhibitory effects of quercetin on cell migration and invasion in HCCLM3 cell are due to its inhibitory effects on MMP2 and MMP9 through altering the PI3K/Akt signaling pathway.
In summary, our study provides a novel mechanistic insight that quercetin inhibits cell migration and invasion in HCCLM3 cell in vitro, and that these anti-migration and anti-invasion effects of quercetin are due to its capacity to down-regulate the expression of MMP-2 and MMP-9 by altering the PI3K/Akt signaling pathway in HCCLM3 cells. Therefore, these data support the possibility of quercetin has value as an efficient anti-cancer cell migration and invasion agent to improve hepatocellular carcinoma treatment.
Conclusions
Our study provides evidence that quercetin inhibits cell migration and invasion in HCCLM3 cells in vitro by down-regulating the expression of MMP-2 and MMP-9 through the PI3K/Akt signaling pathway. Therefore, quercetin may be a novel agent for treatment of hepatocellular carcinoma.
